Blood Pressure Medication Recall Upgraded To Class II — Here’s What To Know
on • Updated
FDA Announces Second Recall For Popular Blood Pressure Medication
Over the past few months, more than 25,000 tablet bottles of a commonly prescribed blood pressure medication have been recalled after the tablets failed to dissolve properly, according to the U.S. Food and Drug Administration (FDA).
Inventia Healthcare issued its initial recall for the medication on June 5, affecting 11,460 bottles of chlorthalidone. The company announced a second recall on September 3, involving an additional 13,567 bottles.
Chlorthalidone is a diuretic, also known as a water pill, that helps lower blood pressure by increasing urine production and reducing the amount of salt and water in the body.
Dissolution testing determines how quickly a medication breaks down and releases its active ingredient in the body. If a drug does not dissolve at the expected rate, it can affect how the medication is absorbed and potentially impact how well it works.
The FDA has now classified both recalls under a Class II category. A Class II recall involves a situation where using or being exposed to a recalled product may cause temporary or medically reversible health problems, or when the likelihood of serious health consequences is considered remote.
What Are The Details Of The Recall?
According to the FDA, the recall involves Inventia Healthcare Limited’s 25-milligram chlorthalidone tablets, which were sold in 100- and 1,000-tablet bottles. The affected tablets have an expiration date of April 2027 and include the lot codes RISA24001, RISB24002 and RISA24002.
No illnesses or injuries linked to the recalled medication had been reported at the time of the recall. Patients who take chlorthalidone should check their prescription bottles and reach out to a pharmacist or health care provider if they determine they have an affected bottle.
